SMA
Sage Mountain Advisors’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Buy |
2,580
+153
| +6% | +$62K | 0.07% | 135 |
|
|
2025
Q1 | $1.21M | Buy |
2,427
+8
| +0.3% | +$3.98K | 0.09% | 98 |
|
|
2024
Q4 | $1.26M | Buy |
2,419
+468
| +24% | +$243K | 0.09% | 99 |
|
|
2024
Q3 | $1.21M | Buy |
1,951
+57
| +3% | +$35.3K | 0.1% | 97 |
|
|
2024
Q2 | $1.05M | Buy |
1,894
+446
| +31% | +$247K | 0.1% | 96 |
|
|
2024
Q1 | $842K | Buy |
1,448
+272
| +23% | +$158K | 0.09% | 108 |
|
|
2023
Q4 | $624K | Sell |
1,176
-172
| -13% | -$91.3K | 0.07% | 112 |
|
|
2023
Q3 | $682K | Buy |
1,348
+75
| +6% | +$38K | 0.09% | 91 |
|
|
2023
Q2 | $664K | Sell |
1,273
-10
| -0.8% | -$5.22K | 0.09% | 94 |
|
|
2023
Q1 | $739K | Buy |
1,283
+741
| +137% | +$427K | 0.12% | 77 |
|
|
2022
Q4 | $298K | Buy |
542
+64
| +13% | +$35.2K | 0.07% | 108 |
|
|
2022
Q3 | $242K | Buy |
478
+61
| +15% | +$30.9K | 0.06% | 135 |
|
|
2022
Q2 | $227K | Buy |
417
+66
| +19% | +$35.9K | 0.04% | 400 |
|
|
2022
Q1 | $207K | Sell |
351
-199
| -36% | -$117K | 0.03% | 455 |
|
|
2021
Q4 | $367K | Buy |
550
+80
| +17% | +$53.4K | 0.04% | 391 |
|
|
2021
Q3 | $269K | Buy |
+470
| New | +$269K | 0.04% | 378 |
|